Cargando…

EPSTI1 as an immune biomarker predicts the prognosis of patients with stage III colon cancer

OBJECTIVE: The poor prognosis and heterogeneity of stage III colon cancer (CC) suggest the need for more prognostic biomarkers. The tumor microenvironment (TME) plays a crucial role in tumor progression. We aimed to explore novel immune infiltration-associated molecules that serve as potential progn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xitao, Cheng, Wei, Zeng, Xingzhi, Dou, Xiaolin, Zhou, Zhongyi, Pei, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623419/ https://www.ncbi.nlm.nih.gov/pubmed/36330510 http://dx.doi.org/10.3389/fimmu.2022.987394

Ejemplares similares

The new ‘coN’ staging system combining lymph node metastasis and tumour deposit provides a more accurate prognosis for TNM stage III colon cancer
por: Wang, Xitao, et al.
Publicado: (2022)

Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
por: Zhou, Rui, et al.
Publicado: (2018)

CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis
por: Zhang, Yue, et al.
Publicado: (2022)

EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection
por: Meng, Xianghe, et al.
Publicado: (2015)

Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer
por: Song, Xiangping, et al.
Publicado: (2021)

Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
por: Li, Xinyu, et al.
Publicado: (2020)

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
por: Chen, Bo, et al.
Publicado: (2018)

circEPSTI1 regulates ovarian cancer progression via decoying miR‐942
por: Xie, Jing, et al.
Publicado: (2019)

Breast Cancer Genes PSMC3IP and EPSTI1 Play a Role in Apoptosis Regulation
por: Capdevila-Busquets, Eva, et al.
Publicado: (2015)

Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR‐578/EPSTI1 axis
por: Zeng, Xuehui, et al.
Publicado: (2023)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy
por: Wang, Zheng, et al.
Publicado: (2022)

Predictive biomarkers of colon cancer immunotherapy: Present and future
por: Hou, Wanting, et al.
Publicado: (2022)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer
por: Wu, Peng, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
por: Chen, Rui, et al.
Publicado: (2022)

Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer
por: Xu, Yansong, et al.
Publicado: (2020)

Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma
por: Sun, Ziquan, et al.
Publicado: (2022)

Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis
por: Yang, Wei, et al.
Publicado: (2022)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma
por: Cheng, Xuehua, et al.
Publicado: (2022)

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
por: Zhang, Jinguo, et al.
Publicado: (2023)

Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
por: Pan, Jing-hua, et al.
Publicado: (2019)

Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
por: Yang, Ruozhu, et al.
Publicado: (2022)

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker
por: Feng, Ziyang, et al.
Publicado: (2022)

Screening and Validation of the Hypoxia-Related Signature of Evaluating Tumor Immune Microenvironment and Predicting Prognosis in Gastric Cancer
por: Pei, Jun-Peng, et al.
Publicado: (2021)

Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery
por: Pei, Qian, et al.
Publicado: (2016)

Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy
por: Wu, Linfang, et al.
Publicado: (2022)

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis
por: Fan, Tao, et al.
Publicado: (2021)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

Wnt5a expression and prognosis in stage II–III colon cancer
por: Lund, Cecilia Margareta, et al.
Publicado: (2020)

Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer
por: Sperlich, Andreas, et al.
Publicado: (2018)

A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy
por: Pan, Runsang, et al.
Publicado: (2022)

CircEPSTI1 Promotes the Progression of Non-Small Cell Lung Cancer Through miR-145/HMGB3 Axis
por: Xie, Yuanyuan, et al.
Publicado: (2020)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
por: Xu, Guozeng, et al.
Publicado: (2021)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma
por: Li, Qiaxuan, et al.
Publicado: (2022)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours
por: Li, Rumeng, et al.
Publicado: (2023)

Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity
por: Wu, Yanlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a4ecmkc2frd4lm7heke65e6jgt